Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

522130

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Dementia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many emergency readmissions within 28 days of discharge there were for patients with a primary or secondary diagnosis of dementia in (a) England and (b) each clinical commissioning group and primary care trust area in each of the last six years.
	tabling member constituency	Worsley and Eccles South
	tabling member printed	Barbara Keeley
	uin	38623
	answer	answer is ministerial correction date of answer 06/06/2016 answer text <p>The information is not held in the format requested.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 06/06/2016 14:17:05 answering member 3918 label Biography information for Jane Ellison
	tabling member	1588 label Biography information for Barbara Keeley

522128

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Fatigue Syndrome
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to address barriers faced by people with ME in accessing care and support; and if he will make a statement.
	tabling member constituency	Stockton North
	tabling member printed	Alex Cunningham
	uin	38801
	answer	answer is ministerial correction date of answer 09/06/2016 answer text <p>The commissioning of services for people with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), is a local matter. To support the local NHS in shaping services for people with CFS/ME, the National Institute for Health and Care Excellence (NICE) has published a clinical guideline on the management of CFS/ME in adults and children, which set outs best practice on the care, treatment and support of people with the condition.</p><p> </p><p>Although there is no cure for CFS/ME, there are treatments that may help to ease symptoms. The NICE guideline on CFS/ME recommends treatment such as cognitive behavioral therapy and graded exercise therapy approaches, which have the clearest research evidence of benefit. However, the guideline is clear that there is no one form of treatment to suit every patient. Treatment approaches will not be appropriate for all patients and the needs and preferences of patients should be taken into account. Shared decision-making between patients and healthcare professionals should take place during diagnosis and all phases of care. Furthermore, patients should be offered information about local and national self-help groups and support groups for people with CFS/ME and their carers.</p><p> </p><p>NICE last reviewed the guidance with its stakeholders, including CFS/ME charities during 2013. The review found no update was required. The full guideline may be viewed on the NICE website at the following link:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg53" target="_blank">www.nice.org.uk/guidance/cg53</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/06/2016 10:59:19 answering member 3918 label Biography information for Jane Ellison
	tabling member	4122 label Biography information for Alex Cunningham

522134

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Electronic Cigarettes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what his policy is on e-cigarettes as a potential gateway to smoking.
	tabling member constituency	St Albans
	tabling member printed	Mrs Anne Main
	uin	38658
	answer	answer is ministerial correction date of answer 10/06/2016 answer text <p>The Government has set a regulatory framework in place that aims to prevent the take up of e-cigarettes by children and non-smokers whilst making them freely available to smokers who wish to use them to quit tobacco use. Gateway effect is difficult to prove or disprove but to date, in the United Kingdom, we have not seen any significant use of e-cigarettes outside of existing smokers and ex-smokers.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/06/2016 10:58:40 answering member 3918 label Biography information for Jane Ellison
	tabling member	1568 label Biography information for Mrs Anne Main

522139

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Electronic Cigarettes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what estimate he has made of the proportion of e-cigarette users who will return to smoking tobacco products in the year ending May 2017 as a result of the Tobacco Products Directive.
	tabling member constituency	St Albans
	tabling member printed	Mrs Anne Main
	uin	38712
	answer	answer is ministerial correction date of answer 10/06/2016 answer text <p>No such estimate has been made given the range of factors which may impact on rates of smoking tobacco and use of e-cigarettes.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/06/2016 11:10:32 answering member 3918 label Biography information for Jane Ellison
	tabling member	1568 label Biography information for Mrs Anne Main

522155

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Neuroendocrine Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment his Department has made of the adequacy of treatment and provision of support through the NHS for patients of neuroendocrine cancer.
	tabling member constituency	Newcastle upon Tyne East
	tabling member printed	Mr Nicholas Brown
	uin	38882
	answer	answer is ministerial correction date of answer 09/06/2016 answer text <p>NHS England has made an assessment of the need for national treatment decisions as to the commissioning of systemic therapies for neuroendocrine carcinomas. Based on this assessment, it has discussed the issue with the National Institute for Health and Care Excellence (NICE) and NICE has agreed to do a multiple technology appraisal of lanreotide, sunitinib, everolimus and peptide receptor radionuclide therapy. NICE guidance on these treatments is due in the summer of 2017. In the meantime, sunitinib is available from the Cancer Drugs Fund and lanreotide is available through routine commissioning.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/06/2016 11:34:48 answering member 3918 label Biography information for Jane Ellison
	tabling member	523 label Biography information for Mr Nicholas Brown

522157

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Blood: Viral Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what research the Advisory Committee on the Safety of Blood, Tissues and Organs plans to undertake or commission on the risk of blood-borne viruses for former sex workers and ex-intravenous drug users.
	tabling member constituency	Kensington
	tabling member printed	Victoria Borwick
	uin	38916
	answer	answer is ministerial correction date of answer 10/06/2016 answer text <p>As a Departmental Expert Committee the Advisory Committee on the Safety of Blood Tissues and Organs (SaBTO) does not undertake or commission research directly. SaBTO is carrying out a review of selection criteria for donation of blood, tissues and cells. The review will be wide-ranging and comprehensive and will include evidence relating to the risks of blood-borne infections in people who have previously injected drugs or received money or drugs for sex. Should any gaps be identified in the course of the review, SaBTO could make research recommendations.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/06/2016 11:08:02 answering member 3918 label Biography information for Jane Ellison
	tabling member	4502 label Biography information for Victoria Borwick

522161

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Neuromuscular Disorders: South East
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to increase provision of neuromuscular care advisor support in (a) London and (b) the South East.
	tabling member constituency	Hendon
	tabling member printed	Dr Matthew Offord
	uin	38885
	answer	answer is ministerial correction date of answer 09/06/2016 answer text <p>The provision of neurological services is a matter for NHS England.</p><p> </p><p>Since 1 April 2013, NHS England has been responsible for commissioning specialised neurological services, which includes services for patients with neuromuscular disorders. NHS England has published a service specification for neurological care, which sets out what providers must have in place to offer evidence-based, safe and effective services. The specification can be found at the following link:</p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/d04-neurosci-spec-neuro.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/d04-neurosci-spec-neuro.pdf</a></p><p><strong> </strong></p><p>NHS England has advised that it commissions two services that provide support to people with neurological conditions:</p><p> </p><p>Firstly a diagnostic service for rare muscular disorders at specified centres:</p><p>- The limb-girdle muscular dystrophies (Newcastle)</p><p>- The congenital muscular dystrophies and myopathies (London – Dubowitz Neuromuscular Centre)</p><p>- The congenital myasthenic syndromes (Oxford)</p><p>- The muscle channelopathies (London – Institute of Neurology)</p><p> </p><p>These providers are required to provide a diagnostic service and support to the referring provider who has on-going responsibility for implementing care.</p><p> </p><p>The second are the services commissioned through Neurosciences: specialist neurology specification. Under this specification providers are required to provide neuromuscular nurses and a neuromuscular care co-ordinator. NHS England commissions the following providers to offer neurology services: Imperial College Healthcare NHS Trust, King’s College Hospital NHS Foundation Trust, Royal Free London NHS Foundation Trust, St George's University Hospitals NHS Foundation Trust, University College London Hospitals NHS Foundation Trust, Barts Health NHS Trust and Barking, Havering and Redbridge University Hospitals NHS Trust.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/06/2016 11:36:20 answering member 3918 label Biography information for Jane Ellison
	tabling member	4006 label Biography information for Dr Matthew Offord

522117

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Department of Health: UK Membership of EU
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will place in the Library copies of all letters, leaflets and other material from his Department circulated to (a) stakeholders and (b) members of the public on the EU referendum; what the costs of the production and distribution of that material has been since 1 January 2016; and what he estimates the cost of any further production and distribution of such material will be between 6 May 2016 and 23 June 2016.
	tabling member constituency	Hazel Grove
	tabling member printed	William Wragg
	uin	38820
	answer	answer is ministerial correction date of answer 09/06/2016 answer text <p>I refer the hon. Member to the answer given by the Minister for the Cabinet Office on 8 June 2016 to Question <a href="http://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2016-05-26/38811/" target="_blank">38811</a>.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/06/2016 08:07:46 answering member 3918 label Biography information for Jane Ellison
	tabling member	4429 label Biography information for Mr William Wragg

522148

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Human Papillomavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, on what date in June 2016 the HPV vaccination pilot for men who have sex with men is planned to commence; and if he will make a statement.
	tabling member constituency	Hazel Grove
	tabling member printed	William Wragg
	uin	38848
	answer	answer is ministerial correction date of answer 10/06/2016 answer text <p>The first sexual health clinics involved in the pilot started offering the human papillomavirus vaccine to men who have sex with men, who are already attending the clinic for an existing appointment, on 6 June 2016.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/06/2016 11:11:30 answering member 3918 label Biography information for Jane Ellison
	tabling member	4429 label Biography information for Mr William Wragg

522153

	registered interest
	date	26/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Human Papillomavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he made of the utility of data from the clinic in Brent and Harrow which has been providing men who have sex with men with HPV vaccinations since 2012 when determining that it was necessary to conduct an HPV vaccination pilot before deciding on a national roll-out; and if he will make a statement.
	tabling member constituency	Hazel Grove
	tabling member printed	William Wragg
	uin	38847
	answer	answer is ministerial correction date of answer 10/06/2016 answer text <p>Experience from the two Brent and Harrow clinics providing human papillomavirus vaccinations to men who have sex with men was shared with Public Health England and has helped to inform the development of the pilot. North West London is unlikely to be representative of England as a whole and the pilot will therefore let us consider provision of this vaccination programme in different geographical areas. It will also consider a wider age range than the service provided in these two clinics. The pilot will cover men up to 45 years of age in line with advice from the Joint Committee on Vaccination and Immunisation (JCVI). The pilot will help resolve a range of implementation issues and determine whether a national programme can be delivered through Genito-Urinary Medicine and HIV clinics at a cost effective price in line with the JCVI’s advice.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/06/2016 10:59:07 answering member 3918 label Biography information for Jane Ellison
	tabling member	4429 label Biography information for Mr William Wragg